Skip to content
2000
Volume 14, Issue 23
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Studying the effects of drugs on the metabolome constitutes a huge part of the metabolomics discipline. Whether the approach is associated with drug discovery (altered pathways due to the disease that provide future targets and information into the mechanism of action or resistance, etc.) or pharmacometabolomics (studying the outcome of treatment), there have been many aspiring published articles in this area. With specific experimental design, including fingerprinting analysis with different analytical platforms in a non-targeted way, the approach is advancing towards the discovery of markers for the implication of personalised medicine, while also providing information that could help to improve the efficacy and reduce the side effects associated with a treatment. In this review, the evolution of pharmacometabolomics from other areas of drug efficacy metabolomics studies is explored.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026614666141215124956
2014-12-01
2025-03-16
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026614666141215124956
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test